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Abstract
Background: MicroRNAs (miRNAs) are a group of small noncoding RNAs that take part in diverse biological
processes by suppressing target gene expression. Relatively few miRNAs have been studied in detail, especially
miR-503, and hence the biological relevance of majority remains to be uncovered. Whether altered expression of
miRNA-503 affects the immunity response to radiotherapy has yet to be addressed.
Results: In the present study, we applied ionizing radiation with a dose of either 0.1 Gy or 5 Gy to irradiate U937
cells to confirm CD40 as a miR-503 target, which was identified using a bioimformatics tool. In high dose (5 Gy)
ionizing-irradiated U937 cells, expression of miR-503 was up regulated while the expression of CD40 gene was
down regulated. Using the transfection of the miR-503 gene into U937 cells and Luciferase assay, we confirmed
that miR-503 suppressed the expression of CD40, and was a negtive regulator of CD40.
Conclusions: To our knowledge, we are the first to describe involvement of miR-503 in radiobiological effect at a
molecular level. This initial finding suggested the evidence that ionizing radiation could alter the expression of
miR-503 and its target gene CD40, and may be very important to shed light on a possible mechanism regarding
regulation of immune responses to irradiation.
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Background
Radiotherapy is a common adjuvant therapy for the
treatment of patients with cancer. However, the effect of
radiation on the immune system always leads to some
side-effects. When living cells are exposed to ionizing
radiation (IR), a series of alterations will take place,
including transformation, cell cycle distress, mutations
and chromosomal aberrations, abnormality of DNA
repair and apoptosis [1,2]. The final outcomes of IR-
exposing cells are determined by the activation of
nuclear pattern [3]. Among the IR-responsive genes,
those for the CD40 pathway have been brought signifi-
cant attention to the field of radiobiological effect
because of their prominent role in orchestrating both
the humoral immune response and the cellular immune
response [4]. The interaction of CD40 on the surface of
B lymphocytes with its ligand (CD45), which is
predominantly expressed by activated T cells, is critical
for the induction of adaptive immunity by promoting
the proliferation and differentiation of B lymphocytes
into immunoglobulin-producing plasma cells. The
CD40-CD154 interactions are also important in the
activation of macrophages and the amplification of the
innate immune response to intracellular and extracellu-
lar pathogens. Disruption of the CD40 pathway would
therefore be predicted to confer deleterious effects on
immune function. Indeed, mutations in the human
CD154 gene results in the X-linked hyper IgM
syndrome, a severe form of immune deficiency disorder
that is clinically manifested by recurrent viral and
bacterial infections and early lethality [5]. However,
expression of the CD40 gene is not restricted to
immune cells but also extends to a variety of other nor-
mal cell types, including fibroblasts, neuronal cells,
epithelial and endothelial cells [6-8]; this widespread
expression indicates that CD40 may play a crucial role
in some physiological events and the pathogenesis of
disease in humans.
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the past decade has uncovered their importance in sev-
eral biological processes and has identified disease states
with altered miRNA expression. miRNAs, a non-coding
RNA family, are 19-25 nt transcripts that play a regula-
tory role in mRNA translation and degradation. There is
a 2-8 nucleotide seed region within each miRNA, which
is thought to be critical for target selection [9]. With
this seed region, mature miRNAs selectively bind to
mRNA recognition elements (MREs) within the 3’-UTR
of target mRNAs. Different target genes may have sev-
eral MREs and therefore be regulated by numerous
miRNAs. Relatively few miRNAs have been studied in
detail, especially miR-503, and hence the biological sig-
nificance of majority remains to be uncovered. Microar-
r a ya n a l y s i si sb e c o m i n gap o w e r f u lt o o lf o ra n a l y s i so f
gene expression profiles. The comprehensive analysis of
microRNA expression patterns in human dermal micro-
vascular endothelial cells (HDMEC) irradiated by 2 Gy
x-rays has recently been reported [10] and showed that
the down-expression of miR-503 proberly takes part in
the innate response mechanism of the endothelium to
radiation. Zhou et al. [11] found that miR-503 can regu-
late metastatic function in hepatocellular carcinoma.
Boominathan et al. [12] reported that tumor suppressors
p53, p73 and p63 are very likely to regulate the proces-
sing of miRNAs such as let-7, miR-200c, miR-143, miR-
107, miR-16, miR-145, miR-134, miR-449a, miR-503,
and miR-21, although the precise mechanism of this
action is largely unknown.
A number of studies have analyzed the transcriptional
regulation of mRNAs and miRNAs in irradiated cells for
better understanding of cellular responses to IR [13,14].
This study was undertaken to apply the Target scan and
miRBase Registry program to investigate if function of
the CD40 gene can be affected by radiation-induced
miR-503 change in U937 cells that are malignant cells
derived from human monocytes. The reason for selec-
tion of U937 cells as the primary test model was
because monocytes could be involved in integrating
innate and adaptive immune responses.
Results
Upregulation of miR-503 expression in
irradiated U937 cells
Following irradiation with either 0.1 Gy or 5 Gy,
increased expression of the miR-503 gene was observed
in the 5-Gy irradiated cells at 3 hours and afterwards,
while reduced expression was observed in 0.1-Gy
irradiated cells at 12 hours and afterwards (Figure 1).
The altered miR-503 expression in the irradiated U937
cells suggested that miR-503 might play an important
role in the response of living cells to radiation.
Underexpression of the CD40 gene in
irradiated U937 cells
T oi d e n t i f yap o s s i b l et a r g e tg e n eo fm i R - 5 0 3 ,w e
computationally predicted targets using the miRBase
Registry program [15] and the TargetScan program [16].
This analysis revealed that the CD40 gene might be a
target of miR-503. Analysis of gene expression at differ-
ent time points after radiation showed an inverse corre-
lation in gene expression between CD40 and miR-503;
the CD40 transcript was significantly overexpressed in
0.1-Gy irradiated cells as compared with that in 5-Gy
irradiated cells (Figure 2A). Western blot analysis
showed that CD40 expression also significantly
increased in 0.1-Gy irradiated cells as compared with
that in 5-Gy irradiated cells (Figure 1B). These results
suggest that miR-503 may reduce CD40 expression at
both the transcriptional and translational levels.
CD40 is a target of miR-503
Analysis with the miRBase Registry and TargetScan pro-
gram showed that miR-503 might interact with CD40.
A ss h o w ni nF i g u r e3 A ,b a s e s2 9 - 3 5o fC D 4 03 ’-UTR
may be the miR-503 target site. Further analysis of the
CD40 3’-UTR binding site for miR-503 with cloned
3’-UTR downstream of the renilla luciferase reporter
gene confirmed that miR-503 was likely to target the
CD40 gene due to the decrement in the renilla activity
(Figure 3B). As shown in Figure 4, transfection of the
miR-503 gene into U937 cells induced inhibition of
CD40 protein expression by 45%.
Discussion
In this study, we applied two doses of radiation (0.59 Gy/
min for 5 Gy radiation and 67 cGy/min for 0.1 Gy radia-
tion) to irradiate U937 cells. The CD40 gene was identi-
fied as a target of miR-503 using bioinformatic tools and
further confirmed by experimental validation. Because a
target locus predicted by combination of algorithms may
have more functional relevance than that predicted using
a single algorithm alone, we analyzed a range of data-
b a s e s .C D 4 0w a sl i s t e da sap r e d i c t e dt a r g e ti nb o t ho f
the target prediction databases interrogated. We have
experimentally validated CD40 as a target of miR-503 by
showing that overexpression of miR-503 resulted in a
decrease of CD40 mRNA expression, protein production
and luciferase activity in a reporter system that contains
the full length CD40 3’-UTR, suggesting direct targeting
by miR-503. We also presented a functional role of CD40
in the signaling pathways induced by radiation and
combined this observation with regulation of CD40 by
miR-503 to draw a conclusion.
The present results suggest that miR-503 may interact
with CD40 and reduce CD40 expression at both the
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Page 2 of 6Figure 1 Ionizing radiation stimulated miR-503 expression in the U937 cell line at different time points. Quantitative PCR showed that
following irradiation up regulation of miR-503 expression was observed in 5.0-Gy irradiated cells at 3 hours and afterwars, while downregulation
of miR-503 regulation in 0.1-Gy irradiated cells at 12 hours and afterwards (*P < 0.01, # P < 0.01)
Figure 2 Expression levels of mRNA and protein of CD40 in irradiated U937 cells. (A) illustrates quantitative RT-PCR analysis of CD40
mRMA expression in irradiated U937 cells at various time points after IR exposure (*P < 0.01); (B) illustrates the levels of CD40 protein that was
examined by western blot in in irradiated U937 cells at various time points after IR exposure; (C) illustrates CD40 protein expression in irradiated
U937 cells at various time points after IR exposure(*P < 0.01).
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case, miR-503 could play an important role in the
response to ionizing radiation through the inhibition of
CD40. Analysis of expression profiling has revealed a
pattern of altered miRNA expression in a variety of
human diseases. Abnormal expression of a number of
miRNAs has been observed in a variety of tumors (e.g.,
miR-34a, miR-143, miR-145, miR-21) [17,18]. Several
miRNAs are also specifically expressed in some types of
cancers [19,20]. Increasing evidence for important roles
Figure 3 Suppression of CD40 expression by miR-503. (A) illustrates the miR-503 target sequence in the CD40 3’UTR that was predicted by
Target Scan; (B) illustrates functional change of the cells transfected with the empty renilla luciferase reporter gene (psiCHECK2) or the reporter
gene fused to the CD40 3’ UTR. “+” represents transfection with a target gene and “-” no transfection. Results are expressed as relative light units
(RLU) and were normalized with the luciferase activity expressed constitutively by the psiCHECK2 vector.
Figure 4 Inhibition of CD40 protein expression in U937 cells transfected with the miR-503 gene. (A) was the result from Western blot
and (B) was the background.
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reported [21-23]. The present work gave further evi-
dence that radiation-induced miRNA expression profiles
may represent a specific response that can trigger a cas-
cade effect on the immune system. However, this
hypothesis needs further investigation.
To our knowledge, we are the first to report the invol-
vement of miR-503 in radiation-induced biological
response. In particular, we observed the altered expres-
sion of miR-503 that is very likely to act as a negative
regulator of the CD40 gene. Our findings have impor-
tant implications regarding regulation of immune
responses to ionizing radiation, which may be useful to
improve clinical effectiveness of radiotherapy for the
treatment of malignant tumors.
Conclusions
In high dose (5 Gy) ionizing-irradiated U937 human
monocyte cells, expression of miR-503 was up regulated
while the expression of CD40 gene was down regulated.
Analysis with the miRBase Registry and TargetScan pro-
gram showed that miR-503 might interact with CD40.
Using the transfection of the miR-503 gene into U937
cells and Luciferase assay, we confirmed that miR-503
suppressed the expression of CD40, and was a negtive
regulator of CD40. Together, This initial finding sug-
gested the evidence that ionizing radiation could alter
the expression of miR-503 and its target gene CD40.
Methods
Cell culture and irradiation
U937 cells were maintained in RPMI 1640 medium and
supplemented with 10% fetal bovine serum, 100 U/ml
penicillin, 100 μg/ml streptomycin, and 2 mM L-gluta-
mine. The cultured cells were divided into two groups,
the high dose irradiated group and the low dose irra-
diated groups. The irradiated groups was exposed to
radiation of either 0.1 Gy or 5 Gy using a 4-MV linear
accelerator (Clinac 4/100, Varian, Palo Alto, CA).
Quantitative RT-PCR analysis
Total RNA was extracted from the cell lines using the
TRIzol method according to the manufacturer’s protocol
[24]. Total RNA was reverse transcribed to cDNA using
Superscript II reverse transcriptase (Invitrogen) and oligo-
nucleotide primers. Quantitative real-time PCR (RT_PCR)
analysis of gene expression was performed in a 25-ul reac-
tion volume containing c D N A ,S Y B RP r e m i xE xT a q
(Takara Bio Inc., Shiga, Japan), TaqMan Universal PCR
Master Mixture and primers for each gene. Quantitation
of miRNAs was carried out using TaqMan microRNA
assays (Applied Biosystems, Foster City, CA). The PCR
amplification was conducted in reaction mixture using the
TaqMan Universal PCR Master Mixture according to the
protocol supplied by the manufacturer. Samples were ana-
lyzed with the ABI PRISM 7000 sequence detection sys-
tem (Applied BioSystems); the specificity of PCR reaction
was determined by melting curve analysis at the dissocia-
tion stage. Specific primers for the CD40 gene were as fol-
lows: 5’-TCTGCACCTGTGAAGAAGGC-3’ (forward)
and 5’-CACATTGGAGAAGAAGCCGA-3’ (reverse); the
GAPDH was used as a reference gene and its PCR primers
included 5’-GAAGGTGAAGGTCGGAGTC-3’ (forward)
and 5’- GAAGATGGTGATGGGATTTC-3’ (reverse).
The relative quantitative method was used for the quanti-
tative analysis and fold change (FC) was used to present
data.
Western blotting
U 9 3 7c e l l sw e r eh a r v e s t e da n dl y s e da tad e s i g n e dt i m e
point of post-radiation; proteins were separated on a
SDS/polyacrylamide gel and transferred into a PVDF
membrane (Bio-Rad, Hercules, CA). After blocking, the
membranes were incubated with the primary antibody,
anti-CD40 polyclonal antib o d y( S a n t aC r u zB i o t e c h n o l -
ogy, Santa Cruz, CA). The membranes were extensively
washed and incubated with a horseradish peroxidase-
conjugated secondary antibody (Bio-Rad). The antigen-
antibody complexes were visualized by West-Q-Chemi-
luminescent Sub Kit Plus (BIOTANG, Waltham, MA).
Constructs and transfection
The precursor of the hsa-miR-503 was amplified from
U937 genomic DNA using the primers 5’-CTCGTGG
GGAAGGTAGAAGG-3’ and 5’-GGGAAAGGGAC-
GAGTCCATC -3’, and the resulting products were cloned
into EcoR1/Not1 restricted pcDNA DEST47 (Invitrogen,
Carlsbad, CA). The expression vector for CD40 was kindly
provided by Jeong et al. (2009), and the construct was
transfected using FuGENE HD (Roche Applied Science,
Mannheim, Germany) according to the manufacturer’s
protocols.
Luciferase assay
The 3’-UTR of the CD40 gene was fused to the renilla
gene using the XhoI/NotI restriction sites of the psi-
CHECK2 vector 4 (Promega). A total of 8 × 10 U937
cells were co-transfected with 30 ng of the indicated
v e c t o ra n d9 0n go ft h ep c D N AD E S T 4 7c l o n e dm i R -
503 using Fugene (HD, Roche) for 48 h. Luciferase
assays were performed using the Dual-Luciferase assay
(Promega). Normalization of the Renilla expression was
performed using the luciferase gene present on the
psiCHECK2 vector.
Statistical analysis
All the statistical tests were performed using the SPSS
for Windows 11.0 software package (SPSS, Chicago, IL,
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of variance (ANOVA) and two-way ANOVA. The signif-
icant level was set at a P-value of < 0.05.
Abbrevations
IR: Ronizing radiation; ANOVA: One-way analysis of
variance.
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Additional file 1: Figure S1. Expression levels of CD40 protein in
irradiated DC cells, Figure S2. Suppression of CD40 expression by
different miRNA. Figure S3. Heatmap illustrating expression of miRNAs in
response to irradiation in H1299 cells. Figure S4. Relative luciferase
activity in the U937 Cells transfected with the empty renilla luciferase
reporter gene (psiCHECK2) and the U937 Cells co-transfected with
psiCHECK2 and miR-503. Table S1. Up-regulated miRNAs in different
radiation sensitivity cell lines.
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